BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Tuesday, May 12, 2026
Home
»
Topics
»
Disease categories and therapies
» Gastrointestinal
Gastrointestinal
RSS
Pyrazine nucleosides target hepatitis C virus polymerase
Nov. 4, 2004
Partial clinical hold lifted from Stanate
Nov. 3, 2004
Roche and Pharmasset to develop new generation HCV therapies
Nov. 2, 2004
Japanese approval for Hepsera
Oct. 29, 2004
Improved nucleoside triphosphate analogue promising against HCV infection
Oct. 27, 2004
CHMP adopts extension of indication for Schering-Plough HCV products
Oct. 27, 2004
Glycine may represent a novel eradication therapy against drug-resistant H. pylori
Oct. 26, 2004
New HCV studies unveiled for PegIntron in difficult-to-treat populations
Oct. 26, 2004
Japanese approval for PegIntron in combination with Rebetol
Oct. 26, 2004
Positive opinion for Fendrix in Europe
Oct. 26, 2004
Previous
1
2
…
486
487
488
489
490
491
492
493
494
…
719
720
Next